Treatment of l dopa dopamine agonist and/or dopamine enhancer induced disorders

• 1. L-DOPA、多巴胺激动剂和/或多巴胺增强剂诱导的紊乱的治疗 [P] . 中国专利： CN103189056A . 2013-07-03
• 2. 多巴胺激动剂加上第一时相胰岛素促分泌剂的组合物用于治疗代谢失调 [P] . 中国专利： CN102458376A . 2012-05-16
• 3. Treatment of L-DOPA, dopamine agonist and/or dopamine enhancer induced disorders [P] . AU2011281336B2 . 2015-03-05

  机译： L-DOPA，多巴胺激动剂和/或多巴胺增强剂引起的疾病的治疗

• 4. TREATMENT OF L-DOPA,DOPAMINE AGONIST AND/OR DOPAMINE ENHANCER INDUCED DISORDERS [P] . ZA201301231B . 2014-04-30

  机译： L-多巴，多巴胺激动剂和/或多巴胺增强剂引起的疾病的治疗

• 5. TREATMENT OF L-DOPA, DOPAMINE AGONIST AND/OR DOPAMINE ENHANCER INDUCED DISORDERS. [P] . MX2013000760A . 2013-10-28

  机译： L-多巴，多巴胺激动剂和/或多巴胺增强剂引起的疾病的治疗。

• 1. Pramipexole, a dopamine D3/D2 receptor-preferring agonist, attenuates reserpine-induced fibromyalgia-like model in mice [J] . Carlos Pereira Martins, Rodrigo Sebben Paes, Gabriela Mantovani Baldasso, 中国神经再生研究（英文版） . 2022,第002期
• 2. Cerebral dopamine neurotrophic factor transfection in dopamine neurons using neurotensin-polyplex nanoparticles reverses 6-hydroxydopamine-induced nigrostriatal neurodegeneration [J] . Manuel A.Fernandez-Parrilla, Claudia Luna-Herrera, Jose Ayala-Davila, 中国神经再生研究（英文版） . 2022,第004期
• 3. Dopamine depletion and subsequent treatment with l-DOPA, but not the long-lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatum. [J] . Bychkov E, Ahmed MR, Dalby KN, Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry . 2007,第3期
• 4. The adenosine A(2A) receptor antagonist, istradefylline enhances anti-parkinsonian activity induced by combined treatment with low doses of L-DOPA and dopamine agonists in MPTP-treated common marmosets [J] . Uchida Shin-ichi, Soshiroda Kazuhiro, Okita Eri, European Journal of Pharmacology: An International Journal . 2015,第Null期
• 5. Repeated treatment with the kappa opioid receptor agonist U69593 reverses enhanced K + induced dopamine release in the nucleus accumbens, but not the expression of locomotor sensitization in amphetamine-sensitized rats [J] . DelPilarEscobarA., CornejoF.A., AndrésM.E., Neurochemistry International: The International Journal for the Rapid Publication of Critical Reviews, Preliminary and Original Research Communications in Neurochemistry . 2012,第4期
• 6. Dopamine Induced Bistability Enhances Signal Processing in Spiny Neurons [C] . Aaron J. Gruber, Sara A. Solla, James C. Houk Annual neural information processing systems conference . 2003
• 7. Glutamate and dopamine transporter modulation: Implications for the treatment of Parkinson's disease and L-DOPA induced dyskinesia. [D] . Chotibut, Tanya. 2014
• 8. Activation of dopamine cell firing by repeated L-DOPA administration to dopamine-depleted rats: its potential role in mediating the therapeutic response to L-DOPA treatment [O] . DG Harden, AA Grace 1995
• 9. Activation of dopamine cell firing by repeated L-DOPA administration to dopamine-depleted rats: its potential role in mediating the therapeutic response to L-DOPA treatment [O] . DG Harden, AA Grace 1995

• 1. Neuroprotection of putative PI-linked D1 dopamine receptor agonist SKF83959 is associated with its attenuation on L-DOPA-induced dyskinesia. [J] . . 中国药理通讯 . 2007,第003期
• 2. Effects of L-Dopa and Dopamine D2 Agonists on Recollection and Familiarity in Idiopathic Nondementing Parkinson’s Disease [J] . Nicola M. J. Edelstyn ,Thomas A. Shepherd ,Andrew R. Mayes . 神经系统科学与医药（英文） . 2011,第4期
• 3. Dopamine and GABA Interaction in Basal Ganglia: GABA-A or GABA-B Receptor Stimulation Attenuates L-DOPA-Induced Striatal and Nigral ERK1/2 Signaling in a Rat Model of Parkinson’s Disease [J] . Sarah Lynch ,Subbiah P. Sivam . 行为与脑科学期刊（英文） . 2013,第6期
• 4. 用美多巴单用联合多巴胺受体激动剂治疗帕金森病的疗效探析 [C] . 邹端 . 2016年广东省药师周大会 . 2015
• 5. 帕金森病人脑脊液神经毒性及单胺氧化酶-B抑制剂和多巴胺激动剂的保护作用的研究 [A] . 孔屏 . 2006